Patrick Cox

Watching this administration pretend that refusing to raise the debt ceiling is the federal government’s real problem — rather than its spending — is simply surreal.

All the major players pushing for more debt, including the president, said exactly the opposite just a few years ago. Roughly, about the time The Daily Reckoning was filming and releasing I.O.U.S.A. Back then, the current powers-that-be were criticizing the prior administration, and rightly so, when the debt was $10 trillion.

Ha. Seems laughably trite, doesn’t it?

Now, when the debt is 60% higher, the same characters are feigning outrage that anybody would take their own prior position in support of a balanced budget.

There is upside to this behavior. Certainty.

We know certain big things will happen. Whenever you know that something big is going to happen, you can make money. And that’s, after all, why you read these pages… to learn how the government and economy actually work, then plan accordingly.

We can project what’s going to happen as a result of current and past fiscal foolishness. As Herbert Stein said, “what can’t go on, won’t.” Attempts to raise taxes further will lead to lower, not greater, revenues. The cost of borrowing will go up, curtailing debt growth and forcing spending cuts.

A primary justification used by this administration for increasing spending and debt has been the expansion of health care programs. The promise of lowering health care costs has already been exposed as a pipe dream, but it has done nothing to diminish the administration’s support of these programs.

In fact, health care costs are going to go up for several reasons, including the bureaucratic burden. Additionally, people are going to live longer while more and better therapies become available. Political pressures to reduce healthcare costs will be enormous.

We’re not speculating wildly, incidentally. Costs are already exploding in places where government established national health care systems earlier, including Canada and the U.K. Rationing, known in medical circles as triage, is reality.

Information is power. If you understand this trend, you can leverage that knowledge, reducing regulatory risk and maximizing ROI by investing in emerging biotechnologies that improve and lower the costs of current medical practices. If a biotechnology does something universally accepted as necessary but does it better and for less money, you have an almost certain blockbuster.

I’ve recommended one such technology to subscribers of my Breakthrough Technology Alert. The company behind this technology has improved continual glucose monitoring with an electronically controlled device that painlessly removes the top layer of dead skin cells, the stratum corneum.

Then, a needle-free sensor measures blood sugar levels in the capillary-rich epidermis and sends that information in real-time to whatever device you choose. Instead of paying nurses to repeatedly draw blood for testing, a constant flow of information is gathered, stored and electronically displayed, eliminating human error for any reading that for some reason is out of line with actual metabolic trends.

Several studies say that continual glucose monitoring can improve hospital outcomes, mortality and length of stay by a third. Cutting hospital stays by a third in a system that pays fixed fees for specific conditions yields huge financial benefits for hospitals. It also saves hours of nursing work every day for every patient having sugars monitored.

This looks to be a breakthrough year for this tiny company, with multiple trigger events coming up soon.

Regards,

Patrick Cox
for The Daily Reckoning

Patrick Cox

Patrick Cox has lived deep inside the world of transformative technologies for over 25 years. This expertise lead him to Mauldin Economics, where he now heads Transformational Technology Alert.

  • Robert (qslv)

    It’s a great technology, but goes completely against the agenda of the powerful pharmecutical lobby. People could stabilize their blood sugar in real time with diet and exercise, losing billions in sales for the big pharma. It would be crushed.

Recent Articles

In the Year 2024

James Rickards

Panopticon goggles? Severe market panic in 2018? Gold confiscation by 2020? Jim Rickards' shocking thought-piece in the spirit of A Brave New World or 1984. Click to see how markets, economics, your money, gold, privacy, wealth building and more look a decade from now in the year 2024...


Our Ebola Stocks Could Double Overnight

Paul Mampilly

I believe we are in the midst of one of the greatest profit opportunities you’re ever going to see in your lifetime. Stop listening to what the government is telling you. Turn off CNN. Forget what you see on the news. And for God’s sake, forget about the market crashing. Right now, we are in the early innings of the greatest profit opportunities of the 21st century. A biotech boom that’s about to hit epic proportions thanks to Ebola. If I’m right, we are going to see Ebola in New York, Los Angeles, San Francisco and Miami. And when this happens, every single stock that has anything to do with Ebola is going to soar. Let me explain to you how I believe this huge Ebola bubble is going to unfold.


Why We Hold Hard Assets II

Henry Bonner

Right now we’re seeing a surge of strength in the U.S. dollar, as the bottom falls out of our competitors’ currencies, and Jim Grant has the best analysis of what it means for investors. For one, it means the Federal Reserve can’t keep interest rates low forever. And mainstream investors may be very surprised when the Fed gives in…


Housing Bulls Gave Up Here… Big Mistake

Greg Guenthner

Another one of Wall Street’s broken forecasts has plopped a new trade in your lap. If you’re listening to the lunatics on the financial news, you’re hearing that there’s no hope for the markets. Just get rid of your stocks and pound sand. Better safe than sorry—none of these talking heads want to get bullish on anything right now because they’re afraid to look like an idiot if the market keeps dropping. For them, selling stocks now is your only chance to make it to the end of the year without pawning the family cat to buy Christmas presents. Can the market survive? Greg Guenthner explains…


A Quarter-Century’s Conclusion on Our Cancer Woes

Ray Blanco

Breakthrough technologies can hold the most undiscovered money-making potential. What we’ve accomplished in a quarter century with cancer research could make you serious money and save countless lives. Ray Blanco has more on this ground breaking story...